OCBJ -- Generic drug maker Teva Pharmaceutical Industries Ltd. said Tuesday it’s resumed production at its Irvine plant.
Israel-based Teva said restarting the Irvine operation was “a significant step for improving its product availability for the U.S. injectable market.”
The drug maker’s Irvine plant had been on a voluntary manufacturing and distribution hold for a year in the wake of quality control and regulatory issues.
